- About one in four U.S. oncologists rarely or never discusses the price of genomic testing with their cancer patients, even though cost is important for informed decision-making, survey results suggest.
To understand when and why doctors do discuss these costs, Yabroff and colleagues analyzed data from a 2017 national survey of cancer doctors. In addition, doctors who had used genomic tests within the previous year tended to talk about cost more. Those who saw higher numbers of patients and who worked in practices that serve more uninsured, self-paid and Medicaid patients also talked about costs more frequently.
Previous studies have indicated that oncologists may not have these conversations due to lack of time, discomfort with discussing costs, limited knowledge about costs and a lack of transparency around costs for specific tests or treatments, the study authors point out.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »